Competitive Landscape of the Ulcerative Colitis Market 2022-2028
The Ulcerative Colitis Market was estimated at US$ 6.6 billion in 2021 and is expected to grow at a CAGR of 5.8% during 2022-2028 to reach US$ 10.9 billion in 2028.
In 2021, North America leads the ulcerative colitis market due to advanced healthcare, awareness, and innovation, while the UK is set for rapid growth and high CAGR, and biosimilars in China and Japan may shift the therapeutic landscape.